![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cubist Conducts Massive Recall Due to Glass Particles
Cubist Conducts Massive Recall Due to Glass Particles
Cubist Pharmaceuticals recalled 101 lots of its antibiotic Cubicin because of a long-standing supplier issue that could have resulted in glass particles in vials.
Drug Industry Daily
Drugs Commercial Operations QualityDrug Industry Daily
Upcoming Events
-
21Oct